These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 22457503

  • 1. MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation.
    Mouri A, Sasaki A, Watanabe K, Sogawa C, Kitayama S, Mamiya T, Miyamoto Y, Yamada K, Noda Y, Nabeshima T.
    J Neurosci; 2012 Mar 28; 32(13):4562-80. PubMed ID: 22457503
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration.
    Ferrés-Coy A, Galofré M, Pilar-Cuéllar F, Vidal R, Paz V, Ruiz-Bronchal E, Campa L, Pazos Á, Caso JR, Leza JC, Alvarado G, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A.
    Mol Psychiatry; 2016 Mar 28; 21(3):328-38. PubMed ID: 26100539
    [Abstract] [Full Text] [Related]

  • 3. Diacylglycerol kinase δ destabilizes serotonin transporter protein through the ubiquitin-proteasome system.
    Lu Q, Murakami C, Hoshino F, Murakami Y, Sakane F.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar 28; 1865(3):158608. PubMed ID: 31891772
    [Abstract] [Full Text] [Related]

  • 4. Serotonin transporter knockdown relieves depression-like behavior and ethanol-induced CPP in mice after chronic social defeat stress.
    Bahi A.
    Behav Brain Res; 2024 May 28; 466():114998. PubMed ID: 38614210
    [Abstract] [Full Text] [Related]

  • 5. Xiaochaihutang attenuates depressive/anxiety-like behaviors of social isolation-reared mice by regulating monoaminergic system, neurogenesis and BDNF expression.
    Ma J, Wang F, Yang J, Dong Y, Su G, Zhang K, Pan X, Ma P, Zhou T, Wu C.
    J Ethnopharmacol; 2017 Aug 17; 208():94-104. PubMed ID: 28687505
    [Abstract] [Full Text] [Related]

  • 6. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.
    Nackenoff AG, Moussa-Tooks AB, McMeekin AM, Veenstra-VanderWeele J, Blakely RD.
    Neuropsychopharmacology; 2016 Jun 17; 41(7):1733-41. PubMed ID: 26514584
    [Abstract] [Full Text] [Related]

  • 7. The roles of MAGE-D1 in the neuronal functions and pathology of the central nervous system.
    Mouri A, Noda Y, Watanabe K, Nabeshima T.
    Rev Neurosci; 2013 Jun 17; 24(1):61-70. PubMed ID: 23314527
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.
    Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA.
    Neuropsychopharmacology; 2010 Dec 17; 35(13):2510-20. PubMed ID: 20827273
    [Abstract] [Full Text] [Related]

  • 9. Genetic deletion of Rgs12 in mice affects serotonin transporter expression and function in vivo and ex vivo.
    White AN, Gross JD, Kaski SW, Trexler KR, Wix KA, Wetsel WC, Kinsey SG, Siderovski DP, Setola V.
    J Psychopharmacol; 2020 Dec 17; 34(12):1393-1407. PubMed ID: 32842837
    [Abstract] [Full Text] [Related]

  • 10. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
    Perona MT, Waters S, Hall FS, Sora I, Lesch KP, Murphy DL, Caron M, Uhl GR.
    Behav Pharmacol; 2008 Sep 17; 19(5-6):566-74. PubMed ID: 18690111
    [Abstract] [Full Text] [Related]

  • 11. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
    Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F.
    Mol Psychiatry; 2012 Jun 17; 17(6):612-23. PubMed ID: 21808255
    [Abstract] [Full Text] [Related]

  • 12. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.
    Ferrés-Coy A, Pilar-Cuellar F, Vidal R, Paz V, Masana M, Cortés R, Carmona MC, Campa L, Pazos A, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A.
    Transl Psychiatry; 2013 Jan 15; 3(1):e211. PubMed ID: 23321808
    [Abstract] [Full Text] [Related]

  • 13. Chronic exposure to imipramine induces a switch from depression-like to mania-like behavior in female serotonin transporter knockout rats: Role of BDNF signaling in the infralimbic cortex.
    Sadighi M, Mai L, Xu Y, Boillot M, Targa G, Mottarlini F, Brambilla P, Gass P, Caffino L, Fumagalli F, Homberg JR.
    J Affect Disord; 2024 Apr 15; 351():128-142. PubMed ID: 38280571
    [Abstract] [Full Text] [Related]

  • 14. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice.
    Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA.
    Biol Psychiatry; 2003 Nov 15; 54(10):960-71. PubMed ID: 14625138
    [Abstract] [Full Text] [Related]

  • 15. Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice.
    Bowman MA, Vitela M, Clarke KM, Koek W, Daws LC.
    Int J Mol Sci; 2020 Oct 14; 21(20):. PubMed ID: 33066466
    [Abstract] [Full Text] [Related]

  • 16. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG, Simmler LD, Baganz NL, Pehrson AL, Sánchez C, Blakely RD.
    ACS Chem Neurosci; 2017 May 17; 8(5):1092-1100. PubMed ID: 28272863
    [Abstract] [Full Text] [Related]

  • 17. The ubiquitination of serotonin transporter in lymphoblasts derived from fluvoxamine-resistant depression patients.
    Mouri A, Ikeda M, Koseki T, Iwata N, Nabeshima T.
    Neurosci Lett; 2016 Mar 23; 617():22-6. PubMed ID: 26845564
    [Abstract] [Full Text] [Related]

  • 18. BDNF Overexpression in the Ventral Hippocampus Promotes Antidepressant- and Anxiolytic-Like Activity in Serotonin Transporter Knockout Rats.
    Diniz DM, Calabrese F, Brivio P, Riva MA, Grandjean J, Homberg JR.
    Int J Mol Sci; 2021 May 10; 22(9):. PubMed ID: 34068707
    [Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA NONHSAG045500 regulates serotonin transporter to ameliorate depressive-like behavior via the cAMP-PKA-CREB signaling pathway in a model of perinatal depression.
    Cui X, Xu Y, Zhu H, Wang L, Zhou J.
    J Matern Fetal Neonatal Med; 2023 Dec 10; 36(1):2183468. PubMed ID: 36997170
    [Abstract] [Full Text] [Related]

  • 20. Developmental alterations in anxiety and cognitive behavior in serotonin transporter mutant mice.
    Sakakibara Y, Kasahara Y, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora I.
    Psychopharmacology (Berl); 2014 Oct 10; 231(21):4119-33. PubMed ID: 24728652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.